You have read all your free articles, to continue reading subscribe to read the rest of this content.
The European Patent Office has approved a novel patent for LIDDS NanoZolid technology. The company's patent protection for the drug delivery technology is now extended for at least another nineteen years. The new patent protects fundamental aspects of the production process of NanoZolid drug dAlready a subscriber Login You have…
Spago Nanomedical has received notice from the Japanese Patent Office (JPO) that it intends to grant the company’s patent application including a critical component of the SpagoPix candidate drug SN132D. JPO has issued a Notice of Allowance which means the patent will be granted following confiAlready a subscriber Login You…
Modus Therapeutics has been granted two patents in the US covering its proprietary compound sevuparin. More specifically the two patents have been granted claims for the substance sevuparin per se and a manufacturing method for producing sevuparin (U.S. Patent no. 9,480,701) as well as its use inAlready a subscriber Login…
Ultimovacs has announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for the company’s US application for a patent covering methods for eliciting a T cell immune response with the UV1 universal cancer vaccine. Subject to grant formalities, the comAlready a subscriber Login…
